From Casetext: Smarter Legal Research

In re Rosuvastatin Calcium Pat. v. Aurobindo

United States Court of Appeals, Federal Circuit
Sep 9, 2010
Nos. 2010-1460, -1461, -1462, -1463, -1464, -1465, -1466, -1467, -1468, -1469, -1470, -1471, -1472, -1473 (Fed. Cir. Sep. 9, 2010)

Opinion

Nos. 2010-1460, -1461, -1462, -1463, -1464, -1465, -1466, -1467, -1468, -1469, -1470, -1471, -1472, -1473.

September 9, 2010.

Appeals from the United States District Court for the District of Delaware in case nos. 08-MD-1949, 07-CV-0810, 07-CV-0805, 07-CV-0809, 07-CV-0811, 07-CV-0806, 08-CV-0426, and 07-CV-0808, Judge Joseph J. Farnan, Jr.


ON MOTION ORDER

Upon consideration of Apotex, Inc., AstraZeneca Pharmaceuticals LP and Aurobindo Pharma USA Inc.'s unopposed motion to be removed as parties in the caption,

IT IS ORDERED THAT:

The motions are granted. The revised official caption is reflected above.


Summaries of

In re Rosuvastatin Calcium Pat. v. Aurobindo

United States Court of Appeals, Federal Circuit
Sep 9, 2010
Nos. 2010-1460, -1461, -1462, -1463, -1464, -1465, -1466, -1467, -1468, -1469, -1470, -1471, -1472, -1473 (Fed. Cir. Sep. 9, 2010)
Case details for

In re Rosuvastatin Calcium Pat. v. Aurobindo

Case Details

Full title:IN RE ROSUVASTATIN CALCIUM PATENT LITIGATION ASTRAZENECA UK LIMITED, IPR…

Court:United States Court of Appeals, Federal Circuit

Date published: Sep 9, 2010

Citations

Nos. 2010-1460, -1461, -1462, -1463, -1464, -1465, -1466, -1467, -1468, -1469, -1470, -1471, -1472, -1473 (Fed. Cir. Sep. 9, 2010)